Butterworth Labs — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Butterworth Laboratories is a long-established, privately-held contract research organization (CRO) providing specialized analytical testing services to the pharmaceutical, medical device, and consumer health industries. Its core business is offering outsourced, regulatory-compliant testing for drug safety, potency, and quality, acting as an extension of its clients' quality control departments. The company leverages over 50 years of experience, a broad technical portfolio, and a client-partnership model to serve a global customer base. Its value proposition is built on regulatory expertise, technical reliability, and flexible service integration into modern supply chains.

Diagnostics

Technology Platform

Suite of established analytical chemistry techniques (e.g., GC, TOC, elemental analysis) deployed within a cGMP-compliant quality management system for pharmaceutical and material testing.

Opportunities

Growth is driven by the pharmaceutical industry's ongoing trend to outsource cGMP analytical testing for quality control and stability.

Additional opportunities exist in expanding services for adjacent sectors like medical devices, cosmeceuticals, and for emerging regulatory needs such as testing for new inhaler propellants (e.g., HFOs) and complex impurities.

Risk Factors

Key risks include intense competition from global and niche contract labs, potential reliance on client R&D spending cycles, and the critical operational risk of maintaining MHRA/FDA certifications.

Any failure in data integrity or quality systems could severely damage the business.

Competitive Landscape

Butterworth Labs competes in the fragmented contract analytical services market against large global CROs (e.g., Eurofins, LabCorp), specialized pharmaceutical testing labs, and in-house client laboratories. Its differentiation is based on over 50 years of niche expertise, a partnership model, deep regulatory knowledge, and its specific MHRA/FDA-approved status.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →